Geneos Wealth Management Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$646
-61.1%
400.0%0.00%
Q2 2023$1,660
-72.3%
40
-55.6%
0.00%
Q3 2022$6,000
-33.3%
90
-33.3%
0.00%
Q2 2022$9,000
-18.2%
1350.0%0.00%
Q1 2022$11,000
+10.0%
135
-6.9%
0.00%
Q4 2021$10,000
+66.7%
145
-27.5%
0.00%
Q4 2018$6,000
+500.0%
200
+100.0%
0.00%
Q1 2016$1,0001000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders